Background and Aims
Publication stageIn Press Accepted Manuscript
Author Contributions: MC and LTG were involved in conceptualizing the project. JT and LTG oversaw project administration. All authors were involved in the formal analysis. JT wrote the first draft, and all authors reviewed, edited, and approved the final draft for submission.
Conflict of interest: These authors disclose the following: MC received consultant fees from Regeneron, Allakos, Adare/Ellodi, Shire/Takeda, AstraZeneca, Sanofi, Bristol Myers Squibb, and Phathom and research funding from Regeneron, Allakos, Shire/Takeda, AstraZeneca, Adare/Ellodi, and Danone. JT is a former employee of Allakos who was employed by Allakos at the time this study was conducted, the data were analyzed, and the manuscript was drafted and reviewed. LTG is an employee of Allakos and owns stocks and stock options.
Funding: The study was funded by Allakos (the sponsor), San Carlos, CA. The sponsor participated in the data analysis and interpretation, preparation, and review of the manuscript.
Data Transparency Statement: Data, analytic methods, and study materials will be made available to other researchers via contacting the corresponding author.
Ethical Statement: The corresponding author, on behalf of all authors, jointly and severally, certifies that their institution has approved the protocol for any investigation involving humans or animals and that all experimentation was conducted in conformity with ethical and humane principles of research.
User LicenseCreative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy